-
Something wrong with this record ?
In vitro antibacterial and antifungal activity of salicylanilide benzoates
Martin Krátký, Jarmila Vinšová, Vladimír Buchta
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NS10367
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 2000
PubMed Central
from 2000
Europe PubMed Central
from 2000
ProQuest Central
from 2012-01-01
Open Access Digital Library
from 2000-01-01 to 2012-01-02
Open Access Digital Library
from 2001-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2012-01-03
Medline Complete (EBSCOhost)
from 2012-01-01
Health & Medicine (ProQuest)
from 2012-01-01
Wiley-Blackwell Open Access Titles
from 2000
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
22666101
DOI
10.1100/2012/290628
Knihovny.cz E-resources
- MeSH
- Anti-Bacterial Agents pharmacology MeSH
- Antifungal Agents pharmacology MeSH
- Benzoates pharmacology MeSH
- Magnetic Resonance Spectroscopy MeSH
- Microbial Sensitivity Tests MeSH
- Salicylanilides pharmacology MeSH
- Spectrophotometry, Infrared MeSH
- In Vitro Techniques MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The resistance to antimicrobial agents brings a need of novel antimicrobial agents. We have synthesized and found the in vitro antibacterial activity of salicylanilide esters with benzoic acid (2-(phenylcarbamoyl)phenyl benzoates) in micromolar range. They were evaluated in vitro for the activity against eight fungal and eight bacterial species. All derivatives showed a significant antibacterial activity against Gram-positive strains with minimum inhibitory concentrations ≥ 0.98 μmol/L including methicillin-resistant Staphylococcus aureus strain. The most active compounds were 5-chloro-2-(3,4-dichlorophenylcarbamoyl)phenyl benzoate and 4-chloro-2-(4-(trifluoromethyl)phenylcarbamoyl)phenyl benzoate. The antifungal activity is significantly lower.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13000753
- 003
- CZ-PrNML
- 005
- 20140905125606.0
- 007
- ta
- 008
- 130108s2012 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1100/2012/290628 $2 doi
- 035 __
- $a (PubMed)22666101
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Krátký, Martin $u Department of Inorganic and Organic Chemistry, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
- 245 10
- $a In vitro antibacterial and antifungal activity of salicylanilide benzoates / $c Martin Krátký, Jarmila Vinšová, Vladimír Buchta
- 520 9_
- $a The resistance to antimicrobial agents brings a need of novel antimicrobial agents. We have synthesized and found the in vitro antibacterial activity of salicylanilide esters with benzoic acid (2-(phenylcarbamoyl)phenyl benzoates) in micromolar range. They were evaluated in vitro for the activity against eight fungal and eight bacterial species. All derivatives showed a significant antibacterial activity against Gram-positive strains with minimum inhibitory concentrations ≥ 0.98 μmol/L including methicillin-resistant Staphylococcus aureus strain. The most active compounds were 5-chloro-2-(3,4-dichlorophenylcarbamoyl)phenyl benzoate and 4-chloro-2-(4-(trifluoromethyl)phenylcarbamoyl)phenyl benzoate. The antifungal activity is significantly lower.
- 650 _2
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 _2
- $a antifungální látky $x farmakologie $7 D000935
- 650 _2
- $a benzoáty $x farmakologie $7 D001565
- 650 _2
- $a magnetická rezonanční spektroskopie $7 D009682
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a salicylanilidy $x farmakologie $7 D012458
- 650 _2
- $a spektrofotometrie infračervená $7 D013055
- 650 _2
- $a techniky in vitro $7 D066298
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vinšová, Jarmila $u Department of Inorganic and Organic Chemistry, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
- 700 1_
- $a Buchta, Vladimír $u Department of Clinical Microbiology, Faculty of Medicine and University Hospital, Charles University, Hradec Králové, the Czech Republic; Department of Biological and Medical Sciences, Faculty of Pharmacy, Charles University, Hradec Králové, the Czech Republic
- 773 0_
- $w MED00181094 $t TheScientificWorldJournal $x 1537-744X $g Roč. 2012(2012), s. 290628
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22666101 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130108 $b ABA008
- 991 __
- $a 20140905130002 $b ABA008
- 999 __
- $a ok $b bmc $g 963535 $s 798917
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 2012 $d 290628 $i 1537-744X $m TheScientificWorldJournal $n ScientificWorldJournal $x MED00181094
- GRA __
- $a NS10367 $p MZ0
- LZP __
- $a Pubmed-20130108